News

VIA Pharmaceuticals Set to Join Russell Micropcap Index - June 27, 2008

Calypso CEO Named E&Y Entrepreneur of the Year in Pacific Northwest - June 20, 2008

PTC Therapeutics Announces Promising Data from PTC124 Studies - June 12, 2008

Protez Pharmaceuticals to be Acquired by Novartis - June 4, 2008

BioSeek to Collaborate with Merck Serono - May 20, 2008

PTC Therapeutics Accnounces Initiation of Phase 2b of PTC124 Trial - April 23, 2008

BrainCells Expands Series B Financing to $50 Million - April 17, 2008

BrainCells Initiates Phase II Trial with BCI-540 for Depression with Anxiety - April 17, 2008

ProGenTech Completes $21 Million Series C Financing - April 2, 2008

Metabolex Initiates Phase I Trial of MBX-2982 - March 26, 2008

Ingenuity Systems Delivers Key Milestones in FDA Collaboration - March 25, 2008

Presidio Pharmaceuticals Gets Exclusive Rights to XTL's HCV NS5A Program - March 20, 2008

VIA Pharmaceuticals Completes Enrollment in P2 VIA-2291 Trials - March 20, 2008

BrainCells Completes $30M Initial Closing of Series B Financing - March 10, 2008

Cadence Pharmaceuticals Completes $49.3M Registered Direct Offering - February 20, 2008

Perlegen and SCLRC to Collaborate on Interferon Response Studies - Februrary 19, 2008

Poniard Announces Positive Results in Prostate Cancer Study - February 15, 2008

Presidio Pharmaceuticals and Numerate Announce Research Collaboration - February 11, 2008

BioSeek Elects Roy Whitfield Executive Chairman of Board of Directors - February 5, 2008

Poniard Appoints Robert De Jager, MD, as Chief Medical Officer - February 4, 2008

Phenomix Files Registration Statement for Proposed IPO - January 25, 2008

MAP Pharmaceuticals Reaches Agreement with FDA for MAP0004 Trial - January 16, 2008

EnteroMedics(TM) Announces 9-Month Results on VBLOC-RF2 Study - January 8, 2008

Mr. Leo Redmond Joins Presidio Pharmaceuticals as Chief Financial Officer - January 7, 2008

MAP Pharmaceuticals Initiates Phase 3 Trial of Unit Dose Budesonide - January 7, 2008

Epocrates Annouces Strategic Investment by Goldman Sachs - January 7, 2008

EnteroMedics(TM) Announces Pivotal EMPOWER Study - January 7, 2008

Aragon Surgical Secures $25 Million in Series B Financing - January 7, 2008

Conatus Initiates Phase 2 Trial for the Treatment of Hepatitis - December 20, 2007

GSK Completes Acquisition of Reliant Pharmaceuticals - December 19, 2007

PTC Therapeutics Announces Additional Grant from SMA Foundation - December 6, 2007

EnteroMedics Announces Initial Public Offering - November 14, 2007

Pathway Diagnostics Announces Patent Issuance - November 15, 2007

BioSeek Appoints Michael C. Venuti, Ph.D., Chief Executive Officer - November 7, 2007

Poniard Announces Positive Preliminary Data for Oral Picoplatin - November 6, 2007

VIA Pharmaceuticals Presents Data at American Heart Assn. Meeting - November 6, 2007

MAP Pharmaceuticals Initiates P2a Clinical Trial in Adult Asthma Patients - October 31, 2007

VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 - October 25, 2007

PTC Therapeutics Announces Additional Positive Results from P2 Study - October 18, 2007

Ingenuity Systems Launches New Metabolomics Solution - October 9, 2007

VIA Pharmaceuticals Announces Positive DSMB Recommendation - October 10, 2007

MAP Pharmaceuticals Announces Exercise of Over-Allotment Option - October 9, 2007

MAP Pharmaceuticals Announces Pricing of Initial Public Offering - October 5, 2007

PTC Therapeutics Announces Additional P2 Results for PTC124 - October 5, 2007

Pathway Diagnostics Announces Availability of SensiTrop(TM) Assay - September 17, 2007

PTC Therapeutics Announces $20M Strategic Investment from Celegene - September 13, 2007

Poniard Receives Fast Track Designation for Picoplatin for SCLC Treatment - September 5, 2007

Presidio Pharmaceuticals Closes $26M Series B Financing - August 29, 2007

VIA Pharmaceuticals Completes $25M Private Placement of Common Stock - August 8, 2007

VIA Pharmaceuticals Announces $25M Private Placement of Common Stock - June 29, 2007

MAP Pharmaceuticals Files Registration Statement for Proposed IPO - June 18, 2007

Intarcia Named as One of the "Fierce 15" Biotech Companies of 2007 - June 6, 2007

Via Pharmaceuticals and Corautus Genetics Complete Merger - June 5, 2007

EnteroMedics Files Registration Statement for Proposed IPO - May 25, 2007

BioSeek Enters Into Collaboration With Amylin; Receives $10M Investment - May 22, 2007

Conatus Completes Second Closing of $27.5M Private Placement Financing - May 9, 2007

Poniard Treats First Patient with Picoplatin in Phase 3 SCLC Study - May 1, 2007

Poniard Pharmaceuticals Announces Pricing of Public Stock Offering - April 25, 2007

PTC Therapeutics Publishes Positive Preclinical Data in Nature - April 23, 2007

Metabolex Raises $32 Million in Series D Financing - April 19, 2007

MAP Pharmaceuticals Closes $50 Million Financing - March 27, 2007

BrainCells and Lundbeck Form CNS Drug Research Collaboration - March 27, 2007

Intarcia Raises $50 Million in a Series BB Financing - March 19, 2007

Phenomix Completes $55 Million Series C Financing - March 8, 2007

Epocrates Launches Two New Mobile Medical Applications - February 27, 2007

Poniard Files NDA for Oral Picoplatin - February 13, 2007

VIA Pharmaceuticals and Corautus Genetics Announce Merger Agreement - February 8, 2007

Calypso 4D Localization System Now In Use at Swedish Cancer Institute - January 30, 2007

PTC Announces Collaboration with Pfizer Utilizing GEMS Technology Platform - January 8, 2007

Syntonix  Acquired by Biogen Idec - January 4, 2007

Conatus Completes $27.5M Private Placement Financing - January 3, 2007